StockData
Inogen Inc logo

Inogen Inc (INGN) stock

INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3068% below fair value
$5.68+0.05 (+0.98%)

Close on Nov 17, 2026Market cap $150.87MP/E –Yield –

Inogen total assets

Total assets on the balance sheet at the end of each period.

Inogen's total assets was $285.57M at Jun 30, 2026. For fiscal 2025 it was $298.63M, up 0.8% from the year before. Over ten years it grew 6.4% a year on average. The highest annual figure on record is $489.51M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$298.63M+0.8%
FY2024Dec 31, 2024$296.19M-9.2%
FY2023Dec 31, 2023$326.19M-19.5%
FY2022Dec 31, 2022$405.04M-17.3%
FY2021Dec 31, 2021$489.51M+6.0%
FY2020Dec 31, 2020$461.85M+3.2%
FY2019Dec 31, 2019$447.34M+19.0%
FY2018Dec 31, 2018$375.90M+36.7%
FY2017Dec 31, 2017$275.07M+28.5%
FY2016Dec 31, 2016$214.05M+32.7%
FY2015Dec 31, 2015$161.31M+15.2%
FY2014Dec 31, 2014$140.09M+70.0%
FY2013Dec 31, 2013$82.40M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$285.57M-8.5%
Q1 FY2026Mar 31, 2026$285.93M-7.3%
Q4 FY2025Dec 31, 2025$298.63M+0.8%
Q3 FY2025Sep 30, 2025$307.01M+0.3%
Q2 FY2025Jun 30, 2025$312.04M+1.0%
Q1 FY2025Mar 31, 2025$308.41M-2.3%
Q4 FY2024Dec 31, 2024$296.19M-9.2%
Q3 FY2024Sep 30, 2024$306.17M-10.9%
Q2 FY2024Jun 30, 2024$308.92M-17.5%
Q1 FY2024Mar 31, 2024$315.60M-18.2%
Q4 FY2023Dec 31, 2023$326.19M-19.5%
Q3 FY2023Sep 30, 2023$343.70M-26.8%
Q2 FY2023Jun 30, 2023$374.35M-20.4%
Q1 FY2023Mar 31, 2023$385.67M-18.7%
Q4 FY2022Dec 31, 2022$405.04M-17.3%
Q3 FY2022Sep 30, 2022$469.58M-8.4%
Q2 FY2022Jun 30, 2022$470.07M-5.6%
Q1 FY2022Mar 31, 2022$474.62M-0.4%
Q4 FY2021Dec 31, 2021$489.51M+6.0%
Q3 FY2021Sep 30, 2021$512.86M+11.4%
Q2 FY2021Jun 30, 2021$498.17M+8.7%
Q1 FY2021Mar 31, 2021$476.48M+3.8%
Q4 FY2020Dec 31, 2020$461.85M+3.2%
Q3 FY2020Sep 30, 2020$460.33M+3.5%
Q2 FY2020Jun 30, 2020$458.12M+13.5%
Q1 FY2020Mar 31, 2020$459.12M+18.3%
Q4 FY2019Dec 31, 2019$447.34M+19.0%
Q3 FY2019Sep 30, 2019$444.73M+24.5%
Q2 FY2019Jun 30, 2019$403.77M+21.4%
Q1 FY2019Mar 31, 2019$388.20M+29.4%
Q4 FY2018Dec 31, 2018$375.90M+36.7%
Q3 FY2018Sep 30, 2018$357.11M+32.3%
Q2 FY2018Jun 30, 2018$332.64M+32.4%
Q1 FY2018Mar 31, 2018$299.88M+31.7%
Q4 FY2017Dec 31, 2017$275.07M+28.5%
Q3 FY2017Sep 30, 2017$269.84M+27.7%
Q2 FY2017Jun 30, 2017$251.23M–
Q1 FY2017Mar 31, 2017$227.63M–
Q4 FY2016Dec 31, 2016$214.05M–
Q3 FY2016Sep 30, 2016$211.31M–

More Inogen figures

See a number that looks wrong?